Guía de Práctica Clínica sobre Trastorno Bipolar - GuíaSalud

149. Bowden C, Gö ü A, Grunze H, Häggström L, Rybakowski J y Vieta E. A 12-week, open,
randomized trial comparing sodium valproate to lithium in patients with bipolar I
disorder suffering from a manic episode. International clinical psychopharmacology,
2008; 23 (5): 254-262.
150. Bowden CL, Brugger AM, Swann AC, Calabrese JR, Janicak PG y Petty F. Efficacy of
divalproex vs lithium and placebo in the treatment of mania The Depakote Mania Study
Group. JAMA, 1994; 271: 918-924.
151. Bowden CL, Grunze H, Mullen J, Brecher M, Paulsson B, Jones M, Vagero M y
Szensson K. A randomised, double blind, placebo controlled efficacy and safety study of
Quetiapine or Lithium as monotherapy for mania in Bipolar disorder. Journal of Clinical
Psychiatry, 2005; 66 (1): 111-121.
152. Freeman TW, Clothier JL, Pazzaglia P, Lesem MD y Swann AC. A double-blind
comparison of valproate and lithium in the treatment of acute mania American Journal of
Psychiatry,, 1992; 149: 108-111.
153. Garfinkel PE, Stancer HC y Persad E. A comparison of haloperidol, lithium carbonate
and their combination in the treatment of mania. Journal of affective disorders, 1980; 2:
279-288.
154. Ichim L, Berk M y Brook S. Lamotrigine compared with lithium in mania: a double-blind
randomized controlled trial. Annals of Clinical Psychiatry, 2000; 12: 5-10.
155. Lerer B, Moore N, Meyendorff E, Cho SR y Gershon S. Carbamazepine versus lithium in
mania: a double-blind study. Journal of Clinical Psychiatry, 1987; 48: 89-93.
156. Segal J, Berk M y Brook S. Risperidone compared with both lithium and haloperidol in
mania: a double-blind randomized controlled trial. Clinical Neuropharmacology, 1998;
21: 176-180.
157. Shopsin B, Gershon S, Thompson H y Collins P. Psychoactive drugs in mania A
controlled comparison of lithium carbonate, chlorpromazine, and haloperidol. Archives of
General Psychiatry, 1975; 32: 34-42.
158. Small JG, Klapper MH, Milstein V, Kellams JJ, Miller MJ, Marhenke JD y Small I.
Carbamazepine compared with lithium in the treatment of mania. Archives of General
Psychiatry, 1991; 48: 915-921.
159. Geller B, Cooper TB, Sun K, Zimerman B, Frazier J y Williams M. Double-blind and
placebo-controlled study of lithium for adolescent bipolar disorders with secondary
substance dependency. Journal of the American Academy of Child & Adolescent
Psychiatry, 1998; 37: 171-178.
160. Keck P, Orsulak P, Cutler A, Sanchez R, Torbeyns A, Marcus R, McQuade R y Carson
W. Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized
double-blind placebo- and lithium-controlled study. J Affect Disord, 2009; 112 (36-49).
161. Cipriani A, Barbui C, Salanti G, Rendell J, Brown R, Stockton S, Purgato M, Spineli LM,
Goodwin GM y Geddes JR. Comparative efficacy and acceptability of antimanic drugs in
acute mania: a multiple-treatments meta-analysis. Lancet, 2011; 378 (9799): 1306-1315.
162. Yildiz A, Vieta E, Leucht S y Baldessarini RJ. Efficacy of antimanic treatments: metaanalysis
of randomized, controlled trials. Neuropsychopharmacology, 2011; 36 (2): 375-
389.
163. Lusznat RM, Murphy DP y Nunn CM. Carbamazepine vs lithium in the treatment and
prophylaxis of mania. British Journal of Psychiatry, 1988; 153: 198-204.
164. Pande AC, Crockatt JG, Janney CA, Werth JL y Tsaroucha G. Gabapentin in bipolar
disorder: a placebo-controlled trial of adjunctive therapy Gabapentin Bipolar Disorder
Study Group. Bipolar Disorders, 2000; 2: 249-255.
165. Weisler RH, Kalali AH y Ketter TA. A multicenter, randomised, double-blindplacebocontrolled
trial of extended-release carbamazepine capsules as montherapy for bipolar
patients with manic or mixed episodes. Journal of Clinical Psychiatry, 2004; 65: 478-484.
166. Weisler RH, Keck PE, Swann AC, Cutler AJ, Jetter TA y Kalali AH. Extended -Release
Carbamazepine capsules as monotherapy for acute mania in bipolar: A multicenter,
408 SANIDAD